Evidence map›Paper›PMID 40904112›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2025

Bacteria-phage infection network structure and genomic defence system content predict efficacy of a phage therapy cocktail against

Maisie R Czernuszka, Taoran Fu, Anastasia Kottara, Michael A Brockhurst, Rosanna C T Wright

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Preface: the ecology and evolution of bacterial immune systems.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  2. Bacteria-phage infection network structure and genomic defence system content predict efficacy of a phage therapy cocktail againstPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maisie R CzernuszkaDivision of Evolution, Infection and Genomics, University of Manchester, Manchester M13 9PT, UK.
Taoran FuDivision of Evolution, Infection and Genomics, University of Manchester, Manchester M13 9PT, UK.ORCID 0000-0003-4683-2171
Anastasia KottaraDivision of Evolution, Infection and Genomics, University of Manchester, Manchester M13 9PT, UK.
Michael A BrockhurstDivision of Evolution, Infection and Genomics, University of Manchester, Manchester M13 9PT, UK.ORCID 0000-0003-0362-820X
Rosanna C T WrightDivision of Evolution, Infection and Genomics, University of Manchester, Manchester M13 9PT, UK.ORCID 0000-0002-8095-8256

Funding

Biotechnology and Biological Sciences Research CouncilManchester Biomedical Research CentreUniversity of ManchesterWellcome Trust 220243
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BacteriophagesPhage TherapyPseudomonas aeruginosaPseudomonas InfectionsPseudomonas PhagesGenome, BacterialHumansanti-phage defence systembacteria–phage infection networkchronic infectionphage therapyPseudomonas aeruginosa

Identifiers

PMID40904112
PMCPMC12409361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.